Sharda Cropchem Ltd

Sharda Cropchem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sharda Cropchem Ltd

₹ 544 -1.20%
02 May - close price
shardacropchem.com BSE: 538666 NSE: SHARDACROP
About

Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 4,906 Cr.
  • Current Price ₹ 544
  • High / Low ₹ 887 / 345
  • Stock P/E 18.0
  • Book Value ₹ 233
  • Dividend Yield 0.55 %
  • ROCE 9.48 %
  • ROE 6.64 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 18.5%

Cons

  • The company has delivered a poor sales growth of 10.2% over past five years.
  • Company has a low return on equity of 13.2% over last 3 years.
  • Earnings include an other income of Rs.164 Cr.
  • Company has high debtors of 205 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Part of BSE SmallCap Nifty Microcap 250 Nifty Total Market BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
710 1,232 580 587 853 1,292 487 431 498 1,187 657 590 800
551 989 578 548 682 1,015 567 442 464 954 585 528 726
Operating Profit 159 243 2 39 172 277 -80 -10 34 234 73 61 74
OPM % 22% 20% 0% 7% 20% 21% -17% -2% 7% 20% 11% 10% 9%
6 2 20 33 63 58 81 54 81 55 16 13 81
Interest 0 1 1 0 1 2 1 4 0 -0 0 0 0
Depreciation 59 72 55 60 65 68 70 74 69 54 65 69 69
Profit before tax 106 173 -34 11 169 265 -70 -34 45 234 23 5 86
Tax % 30% 24% -24% 23% 23% 20% -22% -19% 19% 22% 24% 17% 20%
74 132 -26 9 131 211 -55 -28 37 183 18 4 69
EPS in Rs 8.21 14.59 -2.83 0.94 14.51 23.37 -6.08 -3.07 4.08 20.24 1.97 0.45 7.63
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
556 541 769 934 1,129 1,470 1,604 1,616 2,033 2,946 3,313 2,603 3,234
435 408 614 700 851 1,129 1,326 1,386 1,644 2,344 2,809 2,411 2,792
Operating Profit 121 132 156 235 279 341 278 230 389 603 504 192 442
OPM % 22% 24% 20% 25% 25% 23% 17% 14% 19% 20% 15% 7% 14%
19 35 24 63 56 33 56 130 81 48 173 271 164
Interest 0 5 7 7 8 14 19 15 14 13 18 21 1
Depreciation 37 29 23 35 56 70 99 137 170 245 248 267 257
Profit before tax 104 133 150 256 270 290 217 209 285 392 411 175 349
Tax % 32% 33% 35% 33% 30% 33% 34% 8% 26% 28% 21% 22%
70 89 98 172 189 193 144 192 210 283 325 137 273
EPS in Rs 7.80 9.83 10.88 19.08 20.92 21.44 15.96 21.27 23.25 31.36 35.99 15.16 30.29
Dividend Payout % 0% 20% 23% 16% 19% 19% 25% 19% 22% 19% 17% 20%
Compounded Sales Growth
10 Years: 17%
5 Years: 10%
3 Years: 9%
TTM: 19%
Compounded Profit Growth
10 Years: 5%
5 Years: -1%
3 Years: -13%
TTM: 66%
Stock Price CAGR
10 Years: 6%
5 Years: 29%
3 Years: -5%
1 Year: 49%
Return on Equity
10 Years: 16%
5 Years: 14%
3 Years: 13%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 90 90 90 90 90 90 90 90 90 90 90 90 90
Reserves 363 426 497 647 800 975 1,083 1,221 1,412 1,641 1,912 2,022 2,016
0 0 38 2 0 170 0 0 81 47 0 15 11
253 268 298 452 636 840 867 881 1,106 1,652 2,006 1,698 1,430
Total Liabilities 706 785 923 1,191 1,526 2,075 2,040 2,192 2,690 3,431 4,008 3,825 3,548
64 63 87 129 209 226 371 416 544 592 668 708 983
CWIP 88 133 149 210 232 360 220 161 131 212 204 283 0
Investments 98 176 96 92 62 24 213 117 84 136 33 160 337
455 412 591 761 1,022 1,465 1,236 1,498 1,931 2,491 3,103 2,675 2,228
Total Assets 706 785 923 1,191 1,526 2,075 2,040 2,192 2,690 3,431 4,008 3,825 3,548

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
122 143 14 142 123 -15 513 53 202 277 140 163
-110 -146 -25 -65 -75 -139 -314 24 -238 -183 -1 -179
-13 -10 16 -89 -20 132 -215 -60 44 -90 -98 -35
Net Cash Flow -1 -13 6 -12 28 -21 -16 18 9 4 41 -51

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 197 193 165 200 196 206 168 208 196 163 184 205
Inventory Days 81 72 85 82 133 187 110 116 127 151 166 167
Days Payable 165 191 144 215 223 223 200 211 203 194 203 163
Cash Conversion Cycle 113 74 105 68 106 170 79 113 121 120 147 210
Working Capital Days 104 76 100 93 100 139 74 116 113 92 105 149
ROCE % 24% 27% 26% 39% 34% 29% 19% 17% 20% 24% 22% 9%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82%
2.16% 2.37% 2.41% 2.14% 2.00% 2.01% 2.06% 2.14% 2.02% 2.52% 3.77% 4.69%
12.76% 12.93% 12.61% 12.93% 12.75% 12.29% 12.42% 12.41% 12.87% 12.77% 10.07% 10.28%
10.26% 9.88% 10.15% 10.09% 10.44% 10.87% 10.70% 10.63% 10.29% 9.91% 11.33% 10.21%
No. of Shareholders 61,04958,19261,10654,22252,12656,48356,85861,07554,43648,35358,71751,187

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls